Active Ingredient(s): Segesterone Acetate + Ethinyl Estradiol
FDA Approved: * August 10, 2018
Category: Birth Control / Contraceptive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Annovera Overview

Segesterone (INN, USAN),[1][2] also known as 17α-hydroxy-16-methylene-19-norprogesterone or as 17α-deacetylnestorone, is a steroidal progestin of the 19-norprogesterone group that was never marketed.[3] An acetate ester, segesterone acetate, better known as nestorone or elcometrine, is marketed for clinical use.[4] Segesterone acetate produces segesterone as a metabolite.[5] References .mw-parser-outp...

Read more Annovera Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Annovera Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Segesterone Acetate + Ethinyl Estradiol
  • Ring: 0.013mg/24hr + 0.15mg/24hr, 0.15mg + 0.013mg/day
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Annovera: (2 results)

Sorted by National Drug Code
  • 12822-0313 Annovera Vaginal Ring by Qpharma Ab
  • 50261-313 Annovera Vaginal Ring by Therapeuticsmd, Inc.

Drugs with one or more similar ingredients: (207 results)